--- title: "Ubiquinol (Reduced CoQ10) — Evidence, Benefits & Where to Buy | Magellan" description: "Ubiquinol (Reduced CoQ10) — Coenzyme Q10 (CoQ10, ubiquinone) is a fat-soluble compound the body synthesizes and also obtains in small amounts from foods…" url: "https://magellanlongevity.com/p/121.md" canonical: "https://magellanlongevity.com/p/121.html" html: "https://magellanlongevity.com/p/121.html" type: "product" section: "Nutraceuticals & Cellular Energizers" evidence_grade: "Moderate evidence" evidence_tier: "moderate" citations: 27 product_id: 121 price_usd: 46.49 updated: 2026-09-02 author: "Gabriel Radu, DO" author_credentials: "Physiatrist (PM&R). NY medical license 275110. NPI 1376861765." publisher: "Magellan Longevity" content_format: "markdown" license: "Educational content — not medical advice" --- # Ubiquinol (Reduced CoQ10) [Home](https://magellanlongevity.com/) › [Nutraceuticals & Cellular Energizers](https://magellanlongevity.com/c/1.md) › Ubiquinol (Reduced CoQ10) **HTML version:** https://magellanlongevity.com/p/121.html · **In the Magellan app:** https://magellanlongevity.com/#/product/121 ## Key facts | Field | Value | | --- | --- | | Product | Ubiquinol (Reduced CoQ10) | | Category | [Nutraceuticals & Cellular Energizers](https://magellanlongevity.com/c/1.md) | | Evidence grade | Moderate evidence (B) | | Peer-reviewed citations | 27 | | Typical listed price | $46.49 (check the live price) | | Where to buy | [Search Amazon](https://www.amazon.com/s?k=Ubiquinol%20%28Reduced%20CoQ10%29&tag=magellanlong-20) | | Catalog ID | 121 | ## What it is Coenzyme Q10 (CoQ10, ubiquinone) is a fat-soluble compound the body synthesizes and also obtains in small amounts from foods such as oily fish, organ meats, and nuts. Concentrated in the inner mitochondrial membrane, it serves as an essential electron-transport-chain cofactor for cellular ATP (energy) production and also functions as a lipid-soluble antioxidant. Ubiquinol is the fully reduced form of CoQ10; the ubiquinone and ubiquinol forms interconvert in the body as the molecule shuttles electrons, and ubiquinol has shown better oral absorption than ubiquinone in several pharmacokinetic studies. Endogenous CoQ10 levels fall with age and are further lowered by statin drugs, which inhibit a biosynthetic pathway shared with cholesterol. ## Its role in longevity In human trials CoQ10 has been studied mainly as an adjunct in cardiovascular disease: the Q-SYMBIO randomized trial reported roughly halved major adverse cardiovascular events in chronic heart failure, and a 2024 meta-analysis of 33 heart-failure trials found lower all-cause mortality (RR 0.64) and hospitalization (RR 0.50), though a Cochrane review still rates the heart-failure evidence as low certainty. Other meta-analyses suggest modest reductions in systolic blood pressure, improved flow-mediated (endothelial) dilation, and small improvements in lipids, glycemic markers, and fatigue, balanced by a Cochrane review finding no clinically significant blood-pressure effect in primary hypertension and one meta-analysis finding no benefit for statin-associated muscle pain. Ubiquinol-specific trials are fewer but intriguing: high-dose ubiquinol (1,500 mg/day) slowed functional decline in multiple system atrophy in a phase 2 trial, and small trials report improved endothelial function. Much of the mortality data (for example KiSel-10, with benefit persisting at 10 years) comes from CoQ10 combined with selenium, no trial shows CoQ10 extends lifespan in healthy people, and findings are best viewed as promising rather than definitive. This evidence describes the coenzyme Q10 compound and its mechanisms, not this specific commercial ubiquinol product. ## Evidence grade: Moderate evidence - **What the grade means:** Curated grade based on the human and mechanistic evidence for this compound. - **Dose used in studies:** 100–400 mg/day (1,500 mg/day used in a multiple-system-atrophy trial) - **What this grade does not say:** The strongest signal is adjunctive therapy in chronic heart failure (the Q-SYMBIO trial plus a 33-trial meta-analysis), but a Cochrane review rates that evidence low certainty, and most large trials used ubiquinone rather than ubiquinol — ubiquinol's proven advantage is mainly absorption. Benefit is clearest where CoQ10 is depleted (statins, heart failure, high oxidative demand); it is not a proven lifespan intervention in healthy people. ## Where it comes from without a bottle Food, exercise and behaviour routes to the same pathway, each with its citation. | Natural source | How it works | Citation | | --- | --- | --- | | Oily fish, meat & eggs | CoQ10 is a food-active nutrient concentrated in mitochondria-dense animal tissues — fatty fish, meat and eggs are among its richest dietary sources. Your body also makes ubiquinol endogenously, with diet topping up the pool. | Nutrients 2024 [PMID 38613050](https://pubmed.ncbi.nlm.nih.gov/38613050/) | | Variety across CoQ10-rich food groups | A large cohort found that eating CoQ10 from a DIVERSE range of foods (meat, fish, eggs, vegetables, fruit, nuts, dairy) — not megadoses from one source — tracked with lower new-onset hypertension. Variety, not a single supplement, drove the benefit. | Nutrients 2024 [PMID 38613050](https://pubmed.ncbi.nlm.nih.gov/38613050/) | ### What those papers actually say 1. **Oily fish, meat & eggs** Nutrients 2024 · [PMID 38613050](https://pubmed.ncbi.nlm.nih.gov/38613050/) · [DOI 10.3390/nu16071017](https://doi.org/10.3390/nu16071017) > Coenzyme Q10 (CoQ10) is a food active component with blood-pressure-improving properties. 2. **Variety across CoQ10-rich food groups** Nutrients 2024 · [PMID 38613050](https://pubmed.ncbi.nlm.nih.gov/38613050/) · [DOI 10.3390/nu16071017](https://doi.org/10.3390/nu16071017) > A higher diversity score was associated with lower hypertension risk. ## In the news - **Should CoQ10 Supplements Be Part of Your Wellness Routine?** — Cleveland Clinic 2026 [Read it](https://health.clevelandclinic.org/what-is-coq10) > Numerous studies found that people taking daily CoQ10 supplements had a lower risk of major cardiovascular events or death related to heart disease. - **Coenzyme Q10** — Mayo Clinic 2025 [Read it](https://www.mayoclinic.org/drugs-supplements-coenzyme-q10/art-20362602) > CoQ10 may improve congestive heart failure symptoms. Although findings are mixed, CoQ10 might help lower blood pressure. - **What You May Want to Know About Taking CoQ10 and Statins** — Healthline 2025 [Read it](https://www.healthline.com/health/coq10-and-statins) > Some research suggests that CoQ10 supplements benefit people with heart failure, noting that those who took CoQ10 supplements experienced fewer symptoms and complications than those taking a placebo. ## The research Peer-reviewed studies on the active compound. Quotes are verbatim from the cited abstract. Research describes the active mechanism and is not a claim about this specific product. ### Cited studies 1. **Evidence: electron-transport cofactor** Am J Cardiovasc Drugs 2020 · [PMID 31713723](https://pubmed.ncbi.nlm.nih.gov/31713723/) · [DOI 10.1007/s40256-019-00384-y](https://doi.org/10.1007/s40256-019-00384-y) > Ubiquinol led to significant improvement in peripheral endothelial function 2. **Ubiquinol in patients with severe sepsis or septic shock: a randomized, double-blind, placebo-controlled pilot trial** Crit Care 2015 · [PMID 26130237](https://pubmed.ncbi.nlm.nih.gov/26130237/) · [DOI 10.1186/s13054-015-0989-3](https://doi.org/10.1186/s13054-015-0989-3) > significant increase in total CoQ10 levels in the ubiquinol group compared to placebo 3. **Coenzyme Q10 supplementation for prophylaxis in adult patients with migraine-a meta-analysis.** BMJ Open 2021 · [PMID 33402403](https://pubmed.ncbi.nlm.nih.gov/33402403/) · [DOI 10.1136/bmjopen-2020-039358](https://doi.org/10.1136/bmjopen-2020-039358) > CoQ10 appears to have beneficial effects in reducing duration and frequency of migraine attack. 4. **Efficacy of CoQ10 as supplementation for migraine: A meta-analysis.** Acta Neurol Scand 2019 · [PMID 30428123](https://pubmed.ncbi.nlm.nih.gov/30428123/) · [DOI 10.1111/ane.13051](https://doi.org/10.1111/ane.13051) > However, CoQ10 was more effective than placebo in reducing migraine days/month (P < 0.00001) and migraine duration (P = 0.009). 5. **Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial.** Neurology 2005 · [PMID 15728298](https://pubmed.ncbi.nlm.nih.gov/15728298/) · [DOI 10.1212/01.WNL.0000151975.03598.ED](https://doi.org/10.1212/01.WNL.0000151975.03598.ED) > CoQ10 was superior to placebo for attack-frequency, headache-days and days-with-nausea in the third treatment month and well tolerated; 50%-responder-rate for attack frequency was 14.4% for placebo and 47.6% for CoQ10 (number-needed-to-treat: 3). 6. **The effect of coenzyme Q10 on morbidity and mortality in chronic heart failure: results from Q-SYMBIO: a randomized double-blind trial.** JACC Heart Fail 2014 · [PMID 25282031](https://pubmed.ncbi.nlm.nih.gov/25282031/) · [DOI 10.1016/j.jchf.2014.06.008](https://doi.org/10.1016/j.jchf.2014.06.008) > The primary long-term endpoint was reached by 15% of the patients in the CoQ10 group versus 26% in the placebo group (hazard ratio: 0.50; 95% confidence interval: 0.32 to 0.80; p = 0.003) by intention-to-treat analysis. 7. **Cardiovascular mortality and N-terminal-proBNP reduced after combined selenium and coenzyme Q10 supplementation: a 5-year prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.** Int J Cardiol 2012 · [PMID 22626835](https://pubmed.ncbi.nlm.nih.gov/22626835/) · [DOI 10.1016/j.ijcard.2012.04.156](https://doi.org/10.1016/j.ijcard.2012.04.156) > During a follow up time of 5.2 years a significant reduction of cardiovascular mortality was found in the active treatment group vs. the placebo group (5.9% vs. 12.6%; P=0.015). 8. **Micronutrient Supplementation to Reduce Cardiovascular Risk.** J Am Coll Cardiol 2022 · [PMID 36480969](https://pubmed.ncbi.nlm.nih.gov/36480969/) · [DOI 10.1016/j.jacc.2022.09.048](https://doi.org/10.1016/j.jacc.2022.09.048) > coenzyme Q10 supplementation decreased all-cause mortality events (RR: 0.68; 95% CI: 0.49-0.94). 9. **Effects of coenzyme Q10 administration on blood pressure and heart rate in adults: A systematic review and meta-analysis of randomized controlled trials.** Int J Cardiol Cardiovasc Risk Prev 2025 · [PMID 40495903](https://pubmed.ncbi.nlm.nih.gov/40495903/) · [DOI 10.1016/j.ijcrp.2025.200424](https://doi.org/10.1016/j.ijcrp.2025.200424) > This meta-analysis indicates that CoQ10 supplementation may be an effective adjunctive therapy for reducing systolic blood pressure, especially at doses below 200 mg/day and with longer treatment durations. 10. **Dose-Response Effect of Coenzyme Q10 Supplementation on Blood Pressure among Patients with Cardiometabolic Disorders: A GRADE-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials.** Adv Nutr 2022 · [PMID 36130103](https://pubmed.ncbi.nlm.nih.gov/36130103/) · [DOI 10.1093/advances/nmac100](https://doi.org/10.1093/advances/nmac100) > CoQ10 supplementation significantly reduced systolic blood pressure (SBP) (-4.77 mmHg, 95% CI: -6.57, -2.97) in patients with cardiometabolic diseases 11. **Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension.** Cochrane Database Syst Rev 2016 · [PMID 26935713](https://pubmed.ncbi.nlm.nih.gov/26935713/) · [DOI 10.1002/14651858.CD007435.pub3](https://doi.org/10.1002/14651858.CD007435.pub3) > This review provides moderate-quality evidence that coenzyme Q10 does not have a clinically significant effect on blood pressure. 12. **Effect of Coenzyme Q10 Supplementation on Vascular Endothelial Function: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.** High Blood Press Cardiovasc Prev 2024 · [PMID 38630421](https://pubmed.ncbi.nlm.nih.gov/38630421/) · [DOI 10.1007/s40292-024-00630-8](https://doi.org/10.1007/s40292-024-00630-8) > The results demonstrated significant increases in Flow Mediated Dilation (FMD) after CoQ10 supplementation (WMD: 1.45; 95% CI: 0.55 to 2.36; p < 0.02) 13. **Effects of coenzyme Q10 on vascular endothelial function in humans: a meta-analysis of randomized controlled trials.** Atherosclerosis 2011 · [PMID 22088605](https://pubmed.ncbi.nlm.nih.gov/22088605/) · [DOI 10.1016/j.atherosclerosis.2011.10.027](https://doi.org/10.1016/j.atherosclerosis.2011.10.027) > Coenzyme Q10 supplementation is associated with significant improvement in endothelial function. 14. **Six-month supplementation with high dose coenzyme Q10 improves liver steatosis, endothelial, vascular and myocardial function in patients with metabolic-dysfunction associated steatotic liver disease: a randomized double-blind, placebo-controlled trial.** Cardiovasc Diabetol 2024 · [PMID 38987784](https://pubmed.ncbi.nlm.nih.gov/38987784/) · [DOI 10.1186/s12933-024-02326-8](https://doi.org/10.1186/s12933-024-02326-8) > Six-month treatment with high-dose coenzyme-Q10 reduces liver steatosis and improves endothelial, vascular and left ventricle myocardial function in patients with MASLD, demonstrating significant improvements in micro- and macro-vasculature function. 15. **Associations of coenzyme Q10 with endothelial function in hemodialysis patients.** Nephrology (Carlton) 2020 · [PMID 32749777](https://pubmed.ncbi.nlm.nih.gov/32749777/) · [DOI 10.1111/nep.13766](https://doi.org/10.1111/nep.13766) > A significant correlation was observed between FMD and plasma CoQ10 level (r = 0.727, P < 0.001). 16. **Effect of Coenzyme Q10 Supplementation on Serum of High Sensitivity c-reactive Protein Level in Patients with Cardiovascular Diseases: A Systematic Review and Meta-analysis of Randomized Controlled Trials.** Int J Prev Med 2018 · [PMID 30283614](https://pubmed.ncbi.nlm.nih.gov/30283614/) · [DOI 10.4103/ijpvm.IJPVM_263_17](https://doi.org/10.4103/ijpvm.IJPVM_263_17) > Results of the pooled analysis revealed that the CoQ10 supplementation had no significant effect on the serum level of hs-CRP compared with the placebo group 17. **Effects of coenzyme Q10 supplementation on myopathy in statin-treated patients: a systematic review and meta-analysis.** J Nutr Sci 2025 · [PMID 41158831](https://pubmed.ncbi.nlm.nih.gov/41158831/) · [DOI 10.1017/jns.2025.10043](https://doi.org/10.1017/jns.2025.10043) > Supplementation of CoQ10 can reduce muscle pain in patients with SAMS, which is relevant for their well-being and treatment continuation. 18. **Effect of Coenzyme Q10 on statin-associated myalgia and adherence to statin therapy: A systematic review and meta-analysis.** Atherosclerosis 2020 · [PMID 32179207](https://pubmed.ncbi.nlm.nih.gov/32179207/) · [DOI 10.1016/j.atherosclerosis.2020.03.006](https://doi.org/10.1016/j.atherosclerosis.2020.03.006) > This systematic review and meta-analysis did not demonstrate that CoQ10 supplementation was beneficial for patients with statin-associated muscle pain or improved adherence to statin therapy. 19. **Effectiveness of Coenzyme Q10 Supplementation for Reducing Fatigue: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.** Front Pharmacol 2022 · [PMID 36091835](https://pubmed.ncbi.nlm.nih.gov/36091835/) · [DOI 10.3389/fphar.2022.883251](https://doi.org/10.3389/fphar.2022.883251) > Based on the results of this meta-analysis, we conclude that CoQ10 is an effective and safe supplement for reducing fatigue symptoms. 20. **Effectiveness of Coenzyme Q10 Supplementation for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.** Int J Endocrinol 2018 · [PMID 30305810](https://pubmed.ncbi.nlm.nih.gov/30305810/) · [DOI 10.1155/2018/6484839](https://doi.org/10.1155/2018/6484839) > Based on current evidence, coenzyme Q10 may assist glycemic control, decrease TG, and improve HDL-C in patients with T2DM. 21. **Effects of Coenzyme Q10 Supplementation on Lipid Profiles in Adults: A Meta-analysis of Randomized Controlled Trials.** J Clin Endocrinol Metab 2022 · [PMID 36337001](https://pubmed.ncbi.nlm.nih.gov/36337001/) · [DOI 10.1210/clinem/dgac585](https://doi.org/10.1210/clinem/dgac585) > CoQ10 supplementation decreased the TC, LDL-C, and TG levels, and increased HDL-C levels in adults, and the dosage of 400 to 500 mg/day achieved the greatest effect on TC. 22. **Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis.** J Clin Pharm Ther 2015 · [PMID 25913756](https://pubmed.ncbi.nlm.nih.gov/25913756/) · [DOI 10.1111/jcpt.12280](https://doi.org/10.1111/jcpt.12280) > CoQ10 supplementation has no beneficial effects on glycemic control, lipid profile or blood pressure in patients with diabetes. However, it may reduce triglycerides levels. 23. **Efficacy and safety of coenzyme Q10 in heart failure: a meta-analysis of randomized controlled trials.** BMC cardiovascular disorders 2024 · [PMID 39462324](https://pubmed.ncbi.nlm.nih.gov/39462324/) > In a meta-analysis of 33 randomized heart-failure trials, coenzyme Q10 lowered all-cause mortality (RR 0.64) and heart-failure hospitalization (RR 0.50) and improved ejection fraction and 6-minute walk distance, with moderate GRADE certainty for key outcomes. 24. **Coenzyme Q10 for heart failure.** The Cochrane database of systematic reviews 2021 · [PMID 35608922](https://pubmed.ncbi.nlm.nih.gov/35608922/) > Cochrane review rated the evidence for coenzyme Q10 in heart failure as low to very low certainty and called for larger trials, tempering more optimistic meta-analyses. 25. **High-dose ubiquinol supplementation in multiple-system atrophy: a multicentre, randomised, double-blinded, placebo-controlled phase 2 trial.** EClinicalMedicine 2023 · [PMID 37256098](https://pubmed.ncbi.nlm.nih.gov/37256098/) > In a multicentre double-blind phase 2 RCT (n=139), high-dose ubiquinol (1,500 mg/day) slowed functional decline in multiple system atrophy (UMSARS part 2 difference -1.7 vs placebo) and was well tolerated. 26. **Ubiquinol Ameliorates Endothelial Dysfunction in Subjects with Mild-to-Moderate Dyslipidemia: A Randomized Clinical Trial.** Nutrients 2020 · [PMID 32326664](https://pubmed.ncbi.nlm.nih.gov/32326664/) > Randomized trial in which ubiquinol improved endothelial function in people with mild-to-moderate dyslipidemia. 27. **Reduced Cardiovascular Mortality 10 Years after Supplementation with Selenium and Coenzyme Q10 for Four Years: Follow-Up Results of a Prospective Randomized Double-Blind Placebo-Controlled Trial in Elderly Citizens.** PLoS One 2015 · [PMID 26624886](https://pubmed.ncbi.nlm.nih.gov/26624886/) · [DOI 10.1371/journal.pone.0141641](https://doi.org/10.1371/journal.pone.0141641) > A multivariate Cox regression analysis demonstrated a reduced cardiovascular mortality risk in the active treatment group (HR: 0.51; 95%CI 0.36-0.74; P = 0.0003). ## Where to buy [Search Amazon for Ubiquinol (Reduced CoQ10)](https://www.amazon.com/s?k=Ubiquinol%20%28Reduced%20CoQ10%29&tag=magellanlong-20) — affiliate search link. ## Structured data ```json {"@context":"https://schema.org","@graph":[{"@type":"ItemPage","@id":"https://magellanlongevity.com/p/121.html#page","url":"https://magellanlongevity.com/p/121.html","name":"Ubiquinol (Reduced CoQ10)","description":"Coenzyme Q10 (CoQ10, ubiquinone) is a fat-soluble compound the body synthesizes and also obtains in small amounts from foods such as oily fish, organ…","inLanguage":"en","isPartOf":{"@type":"WebSite","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"author":{"@type":"Person","name":"Gabriel Radu, DO","jobTitle":"Physiatrist (PM&R)","identifier":[{"@type":"PropertyValue","name":"NPI","value":"1376861765"},{"@type":"PropertyValue","name":"NY medical license","value":"275110"}]},"publisher":{"@type":"Organization","name":"Magellan Longevity","url":"https://magellanlongevity.com/"},"encoding":{"@type":"MediaObject","encodingFormat":"text/markdown","contentUrl":"https://magellanlongevity.com/p/121.md"},"dateModified":"2026-09-02"},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://magellanlongevity.com/"},{"@type":"ListItem","position":2,"name":"Nutraceuticals & Cellular Energizers","item":"https://magellanlongevity.com/c/1.html"},{"@type":"ListItem","position":3,"name":"Ubiquinol (Reduced CoQ10)","item":"https://magellanlongevity.com/p/121.html"}]},{"@type":"Product","@id":"https://magellanlongevity.com/p/121.html#product","name":"Ubiquinol (Reduced CoQ10)","category":"Nutraceuticals & Cellular Energizers","url":"https://magellanlongevity.com/p/121.html","description":"Coenzyme Q10 (CoQ10, ubiquinone) is a fat-soluble compound the body synthesizes and also obtains in small amounts from foods such as oily fish, organ meats, and nuts. Concentrated in the inner mitochondrial membrane, it serves as an essential electron-transport-chain cofactor for cellular ATP…","additionalProperty":[{"@type":"PropertyValue","name":"Evidence grade","value":"Moderate evidence"}],"offers":{"@type":"Offer","priceCurrency":"USD","price":"46.49","url":"https://www.amazon.com/s?k=Ubiquinol%20%28Reduced%20CoQ10%29&tag=magellanlong-20","availability":"https://schema.org/InStock"}}]} ``` ## Related on Magellan Longevity - [Omega-3 EPA/DHA Fish Oil](https://magellanlongevity.com/p/128.md) — Across large randomized trials and meta-analyses, marine omega-3s reliably reduce serum triglycerides… - [Creatine Monohydrate](https://magellanlongevity.com/p/123.md) — Across meta-analyses and randomized trials, creatine monohydrate combined with resistance training modestly… - [Astaxanthin Softgels](https://magellanlongevity.com/p/107.md) — In humans, randomized trials and meta-analyses most consistently show that astaxanthin lowers the… - [Zinc Picolinate](https://magellanlongevity.com/p/133.md) — Multiple meta-analyses of randomized trials indicate that oral zinc, started soon after symptom onset, can… - [Vitamin K2 (MK-7)](https://magellanlongevity.com/p/138.md) — In humans, MK-7 supplementation consistently improves vitamin K-status biomarkers — lowering circulating… - [All Nutraceuticals & Cellular Energizers](https://magellanlongevity.com/c/1.md) - [Evidence-based longevity supplements](https://magellanlongevity.com/longevity-supplements.md) - [Longevity research map](https://magellanlongevity.com/longevity-research-map.html) ## Scope and disclosures Educational information, not medical advice. Nothing here is intended to diagnose, treat, cure, or prevent any disease. Talk to your physician before starting any supplement or device, especially if you are pregnant, nursing, or taking medication. Editorial firewall: evidence grades are assigned from the published research and are independent of any affiliate commission. As an Amazon Associate, Magellan Longevity earns from qualifying purchases. Reviewed for accuracy by a board-certified physician (DO).